FIELD: medicine, pharmacy.
SUBSTANCE: invention describes a pharmaceutical composition as a solid dosed medicinal formulation comprising desmopressin acetate as a therapeutic component in combination with a pharmaceutically acceptable excipient, diluting agent or carrier or their mixture. This pharmaceutical composition consists of pressed granulate and comprises a lubricating substance in the amount from 0.05 to less 0.40 wt.-% of indicated pharmaceutical composition mass. Indicated amount of lubricant provides increasing both pressing rate and strength of prepared tablets simultaneously.
EFFECT: improved and valuable pharmaceutical properties of composition.
35 cl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DESMOPRESSIN-CONTAINING SOLID PHARMACEUTICAL FORMULATION | 2004 |
|
RU2290945C2 |
COMPOSITION CONTAINING DESMOPRESSIN | 2007 |
|
RU2340351C1 |
DOSAGE FORM CONTAINING DESLORATADINE AND METHOD FOR PRODUCING IT | 2013 |
|
RU2550958C2 |
METHOD OF PREPARATION OF HARD MEDICINAL FORM OF DESMOPRESSIN | 2004 |
|
RU2334505C2 |
DESMOPRESSIN MEDICINAL FORMULATION DISPERSED IN MOUTH CAVITY | 2003 |
|
RU2292903C2 |
TIBOLON-STABILIZING COMPOSITIONS | 1998 |
|
RU2207133C2 |
PROLONGED-RELEASE COMPOSITION CONTAINING MICRONIZED TOLCAPONE | 2017 |
|
RU2750670C2 |
SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
PHARMACEUTICAL COMPOSITION COMPRISING A SOLID DISPERSION OF TADALAFIL | 2014 |
|
RU2673228C2 |
IMMEDIATE-RELEASED TABLET | 1999 |
|
RU2252751C2 |
Authors
Dates
2007-07-27—Published
2004-07-19—Filed